Trial Profile
Report of clinical findings in the vitreo-retinal diseases
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 May 2017
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 23 May 2017 New trial record
- 01 Apr 2017 Status changed from recruiting to completed, according to the results published in the Medicine.
- 01 Apr 2017 Results published in the Medicine